Alpha 2.0
Login Register
» Articles » PMID: 19409299

Targeted Therapy for Advanced Non-small Cell Lung Cancers: Historical Perspective, Current Practices, and Future Development

Overview
Journal Curr Probl Cancer
Specialty Oncology
Date 2009 May 5
PMID 19409299
Citations 12
Authors
Devalingam Mahalingam
Alain Mita
Monica M Mita
Steffan T Nawrocki
Francis J Giles
Affiliations
Soon will be listed here.
Citing Articles

A new class of cytotoxic agents targets tubulin and disrupts microtubule dynamics.

Al-Hamashi A, Koranne R, Dlamini S, Alqahtani A, Karaj E, Rashid M Bioorg Chem. 2021; 116:105297.

PMID: 34509798 PMC: 8530978. DOI: 10.1016/j.bioorg.2021.105297.

A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer.

Huang C, Ju D, Chang C, Reddy P, Velmurugan B Biomedicine (Taipei). 2017; 7(4):23.

PMID: 29130448 PMC: 5682982. DOI: 10.1051/bmdcn/2017070423.

Downregulation of carbonic anhydrase IV contributes to promotion of cell proliferation and is associated with poor prognosis in non-small cell lung cancer.

Chen J, Hu L, Zhang F, Wang J, Chen J, Wang Y Oncol Lett. 2017; 14(4):5046-5050.

PMID: 29085519 PMC: 5649559. DOI: 10.3892/ol.2017.6740.

Geographic Variations and Time Trends in Cancer Treatments in Taiwan.

Hsu J, Chang S, Lu C BMC Public Health. 2017; 18(1):89.

PMID: 28768504 PMC: 5541736. DOI: 10.1186/s12889-017-4615-y.

Longitudinal trends in use and costs of targeted therapies for common cancers in Taiwan: a retrospective observational study.

Hsu J, Lu C BMJ Open. 2016; 6(6):e011322.

PMID: 27266775 PMC: 4908913. DOI: 10.1136/bmjopen-2016-011322.